You are here
PolyMedix, Inc.
UEI: N/A
# of Employees: 16
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Development of Small Antimicrobial Peptide Mimics as Drug-Resistant and Susceptib
Amount: $3,000,000.00DESCRIPTION (provided by applicant): Malaria is a global disease causing gt 500 million clinical cases and gt 1 million deaths each year. Moreover, drug resistant Plasmodium falciparum has become a m ...
SBIRPhase II2012Department of Health and Human Services National Institutes of Health -
A Topical Host Defense Peptide Mimetic for Oral Mucositis
Amount: $161,376.00DESCRIPTION (provided by applicant): Oral ulcerative mucositis is a common, painful, dose-limiting toxicity of chemotherapy and radiation therapy for cancer, and represents an important unmet clinica ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health -
A Novel Antimicrobial Mimetic for Oral Candidiasis
Amount: $975,997.00DESCRIPTION (provided by applicant): Oral infections of Candida albicans represent an increasing problem in human health. In immunocompromised individuals, especially those suffering from AIDS, candia ...
SBIRPhase II2010Department of Health and Human Services National Institutes of Health -
Biomimetics for treating biofilm-embedded infections
Amount: $749,860.00Multi-drug resistant (MDR) biofilms are one of the most difficult bacterial infections to treat. Current antibiotics are increasingly unable to cure these infections; underscoring the need to develop ...
STTRPhase II2010Department of Defense Army -
Development of Small Antimicrobial Peptide Mimics as Drug-Resistant and Susceptib
Amount: $999,094.00DESCRIPTION (provided by applicant): Malaria is a global disease causing gt 500 million clinical cases and gt 1 million deaths each year. Moreover, drug resistant Plasmodium falciparum has become a m ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health -
SBIR Phase I:Development of Novel Antimicrobial Sutures
Amount: $150,000.00This Small Business Innovation Research (SBIR) Phase I project is aimed at the development of antimicrobial sutures containing an active agent that displays broad activity against pathogens associated ...
SBIRPhase I2010National Science Foundation -
Biomimetics for treating biofilm-embedded infections
Amount: $749,860.00Multi-drug resistant (MDR) biofilms are one of the most difficult bacterial infections to treat. Current antibiotics are increasingly unable to cure these infections; underscoring the need to develop ...
STTRPhase II2010Department of Defense Army -
Novel Antibacterial Agents
Amount: $69,891.00The need for novel antibiotics is well understood by anyone familiar to the field. We have discovered a novel class of antibiotics that are structurally unique from all previously known antibiotics a ...
STTRPhase I2009Department of Defense Navy -
Biomimetics for treating biofilm-embedded infections
Amount: $100,000.00Multi-drug resistant (MDR) biofilms are perhaps the most difficult bacterial infections to fight. They require novel antibiotics that operate through new mechanisms which overcome the biofilm environ ...
STTRPhase I2009Department of Defense Army -
Development of biomimetic oligomers as anticoagulant antagonists
Amount: $923,075.00DESCRIPTION (provided by applicant): LMWHs are being used with greater frequency to treat deep vein thrombosis, unstable angina, and acute pulmonary embolism, as well as thromboprophylaxis agents in a ...
SBIRPhase II2009Department of Health and Human Services National Institutes of Health